ID3021 Acquired resistance to with EGFR tyrosine kinase inhibitors by the EGFR T790M mutation in non-small cell lung cancer. Biomed. Res. Ther. [Internet]. 2017 Sep. 5 [cited 2024 Nov. 15];4(S):S33. Available from: https://preservation.bmrat.org/index.php/BMRAT/article/view/243